Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | LGALS3 | P17931 | 8/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.51 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.51 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.49 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.49 |
| ▸ | CD69 | Q07108 | 1/20 | 0.48 |
| ▸ | LGALS9 | O00182 | 3/20 | 0.48 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14160272 | 0.87 | LGALS3 (0.58) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566142 | 0.86 | CD69 (0.59) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566005 | 0.86 | CD69 (0.59) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566202 | 0.86 | CD69 (0.59) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9565997 | 0.86 | CD69 (0.59) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566000 | 0.86 | CD69 (0.59) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9565991 | 0.86 | CD69 (0.59) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566129 | 0.85 | CD69 (0.60) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566125 | 0.85 | CD69 (0.60) | ALDH1A1THRBLGALS3LGALS8LGALS4 | |
| SCHEMBL9566119 | 0.85 | CD69 (0.60) | ALDH1A1THRBLGALS3LGALS8LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034925-B2 | Glucosamine and method of making glucosamine from microbial biomass | CARGILL, INCORPORATED (US) | 2011-10-11 | — | — | US | disclosed |
| US-20100222566-A1 | GLUCOSAMINE AND METHOD OF MAKING GLUCOSAMINE FROM MICROBIAL BIOMASS | CARGILL, INCORPORATED | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222566-A1 | GLUCOSAMINE AND METHOD OF MAKING GLUCOSAMINE FROM MICROBIAL BIOMASS | OGT, UGGT1, UGCG | ALDH1A1 2335/4885THRB 2240/4885LGALS3 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.